Preoperative Assessment - ASA Class, Functional Capacity, and Risk Optimization

Key Points

• Preoperative assessment should change management, not merely generate tests.
• ASA class summarizes comorbidity but does not replace procedure-specific risk assessment.
• Functional capacity and frailty help estimate physiologic reserve.
• Use stress testing only when the result would change perioperative care.
• Active unstable cardiac disease may justify delaying elective surgery.
• Continue chronic beta blockers when indicated but do not initiate them immediately before surgery without time for safe titration.
• Medication plans must include anticoagulants, diabetes drugs, SGLT2 inhibitors, and other agents with perioperative consequences.
• Optimization includes anemia, nutrition, smoking, pulmonary disease, OSA, and postoperative planning.

Algorithm

1. Define procedure urgency, physiologic stress, bleeding risk, and expected postoperative needs.
2. Review comorbidities, prior anesthesia history, medications, allergies, frailty, and functional capacity.
3. Identify active unstable cardiovascular or pulmonary disease that changes timing.
4. Estimate perioperative cardiac and general complication risk with validated tools when appropriate.
5. Order only targeted tests whose results would change management.
6. Create medication, anticoagulation, diabetes, and fasting instructions.
7. Optimize modifiable risks without delaying necessary surgery for low-value interventions.
8. Communicate risk, anesthesia considerations, and postoperative monitoring plan.

Clinical Synopsis & Reasoning

Preoperative evaluation should begin with the operation and the patient rather than a checklist of tests. Clarify surgical urgency, expected blood loss, physiologic stress, type of anesthesia, and postoperative care needs. Review prior anesthesia problems, cardiopulmonary disease, kidney and liver disease, diabetes, bleeding history, medications, allergies, frailty, sleep apnea, tobacco and substance use, and baseline cognition or function.

The ASA Physical Status classification communicates global preanesthetic comorbidity burden but is not a complete surgical-risk calculator. Functional capacity remains useful. Inability to perform moderate activities or a low Duke Activity Status Index can identify patients with limited reserve, although subjective estimates are imperfect. The 2024 ACC/AHA perioperative cardiovascular guideline favors a stepwise approach using validated risk tools, functional capacity, biomarkers in selected elevated-risk patients, and testing only when results will alter treatment.

Active unstable cardiovascular conditions, such as acute coronary syndrome, decompensated heart failure, or unstable arrhythmia, can justify postponing elective surgery for evaluation and treatment. Stable chronic disease usually should be optimized without unnecessary delay. Frailty, malnutrition, anemia, uncontrolled diabetes, smoking, poorly treated pulmonary disease, and obstructive sleep apnea can materially affect postoperative complications and deserve targeted planning.

Treatment Strategy & Disposition

Optimization is diagnosis-specific. Continue most chronic cardiovascular therapies, but apply current medication rules for agents with important perioperative effects. Beta blockers already prescribed for an established indication are generally continued; starting a beta blocker immediately before surgery simply to lower heart rate can be harmful. Statins are generally continued. SGLT2 inhibitors require preoperative interruption to reduce perioperative ketoacidosis risk. ACE inhibitors or ARBs may be withheld in selected patients when intraoperative hypotension is a major concern, while continuation can be appropriate in others, particularly heart failure, according to current guidance and institutional practice.

Manage anticoagulants and antiplatelet drugs with a written drug-specific plan. Correct severe anemia when time and cause permit, but do not transfuse simply to normalize a laboratory value. Encourage smoking cessation even when the interval is short. Optimize inhaler therapy in obstructive lung disease. Assess OSA risk and plan postoperative monitoring and opioid-sparing analgesia. Diabetes plans should specify basal insulin, meal insulin, and oral-agent interruption.

Order tests only when they answer a clinical question. CBC is appropriate when anemia or major blood loss is plausible; chemistry testing when renal function or electrolytes matter; ECG for selected cardiovascular-risk patients; pregnancy testing based on patient preferences and institutional policy. Routine chest radiography, coagulation testing, urinalysis, or stress testing in low-risk asymptomatic patients adds false positives more often than benefit. Communicate the final risk, medication instructions, fasting plan, and postoperative destination to the patient and surgical team.

Epidemiology / Risk Factors

• Perioperative complications reflect both patient comorbidity and surgical stress.
• Older adults and patients with frailty have higher postoperative delirium, functional decline, and complication risk.
• Cardiovascular disease remains a major cause of perioperative morbidity in noncardiac surgery.
• Low-value routine testing is common despite guideline recommendations for selective testing.

Investigations

Medication Management Concepts

Pharmacology

Prognosis / Complications

• Good preoperative planning reduces preventable medication, airway, bleeding, and postoperative-monitoring errors.
• Delaying surgery for unnecessary testing can itself cause harm, especially after time-sensitive fractures or cancer diagnoses.
• Optimization benefits are greatest when directed at modifiable high-impact conditions.
• Accurate postoperative disposition planning reduces rescue failures after major surgery.

Patient Education / Counseling

• Give written instructions for which medications to take or hold and when.
• Explain that not ordering a test can be evidence-based when it would not change care.
• Encourage smoking cessation and pulmonary optimization before surgery.
• Tell patients to report new chest pain, dyspnea, infection, or medication changes before the procedure.
• Discuss expected pain-control strategy and postoperative level of monitoring.

Notes

The ASA class is useful communication but is sometimes misused as a predicted mortality percentage. Surgical risk, frailty, procedure urgency, and physiologic reserve still require separate assessment.

The 2024 ACC/AHA perioperative guideline reinforces the principle that cardiovascular screening and treatment should generally follow the same indications that would apply outside surgery. Surgery is not, by itself, a reason for indiscriminate stress testing or coronary intervention.

References

1. 2024 ACC/AHA Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery — Link
2. ASA Standards and Practice Parameters — Link